Atlassian Corporation PLC vs 10X Genomics Inc — how do they compare? Atlassian Corporation PLC trades at $90.61 (market cap $23.67B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Atlassian Corporation PLC is far larger — about 4.3× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Atlassian Corporation PLC nearer its low. Which is the better fit depends on your goals.
| TEAM | TXG | |
|---|---|---|
Market Cap | $23.67B | $5.48B |
Sector | Technology | Health |
52-Week High | $203.00 | $45.80 |
52-Week Low | $57.15 | $11.34 |
Enterprise Value | $23.78B | $5.02B |
Trailing returns across standard periods
Latest headlines on both assets
Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.
Read more on TEAM →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →